PPD Development, LP
172
18
27
109
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
15.7%
27 terminated/withdrawn out of 172 trials
80.1%
-6.4% vs industry average
33%
56 trials in Phase 3/4
69%
75 of 109 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (172)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Role: lead
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Role: lead
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Role: collaborator
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
Role: lead
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Role: lead
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Role: collaborator
Daratumumab and Belatacept for Desensitization
Role: collaborator
Belimumab With Rituximab for Primary Membranous Nephropathy
Role: collaborator
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Role: collaborator
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
Role: collaborator
Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Role: collaborator
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Role: collaborator
The Anifrolumab PRIM Program
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
Role: collaborator
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Role: collaborator
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Role: collaborator
A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants
Role: collaborator
A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
Role: collaborator
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Role: collaborator